
MaddieBio is a pioneering biotech company focused on affordable whole genome sequencing and AI-driven genetic analysis to empower underserved individuals with personalized health insights. Founded by Gavenraj Sodhi inspired by his daughter's rare disease, the company combines AI, genetics, and advanced analytics to identify genetic predispositions, health risks, and biomarkers, particularly targeting rare diseases like Rett Syndrome. MaddieBio offers personalized genome sequencing tests, AI-powered health reports, and a mobile app for users to track genetic insights. It also collaborates with healthcare providers, researchers, and pharmaceutical companies to accelerate drug repurposing and personalized treatment development, leveraging a comprehensive genomic database and in-silico simulations. The company operates with a mission to transform healthcare through accessible, personalized genetic testing and data-driven therapeutic innovation.

MaddieBio is a pioneering biotech company focused on affordable whole genome sequencing and AI-driven genetic analysis to empower underserved individuals with personalized health insights. Founded by Gavenraj Sodhi inspired by his daughter's rare disease, the company combines AI, genetics, and advanced analytics to identify genetic predispositions, health risks, and biomarkers, particularly targeting rare diseases like Rett Syndrome. MaddieBio offers personalized genome sequencing tests, AI-powered health reports, and a mobile app for users to track genetic insights. It also collaborates with healthcare providers, researchers, and pharmaceutical companies to accelerate drug repurposing and personalized treatment development, leveraging a comprehensive genomic database and in-silico simulations. The company operates with a mission to transform healthcare through accessible, personalized genetic testing and data-driven therapeutic innovation.